Scarica l'app Stockscreener
3.7299
1.93%
0.1099
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché SNOA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.62
Aprire:
$3.62
Volume 24 ore:
30,038
Relative Volume:
0.03
Capitalizzazione di mercato:
$6.13M
Reddito:
$12.31M
Utile/perdita netta:
$-5.08M
Rapporto P/E:
-3.968
EPS:
-0.94
Flusso di cassa netto:
$-5.20M
1 W Prestazione:
-6.35%
1M Prestazione:
+25.08%
6M Prestazione:
+39.25%
1 anno Prestazione:
-56.77%
Intervallo 1D:
$3.57
$3.75
Intervallo di 1 settimana:
$3.50
$4.15
Portata 52W:
$1.75
$9.00
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Nome
Sonoma Pharmaceuticals Inc
Settore
Telefono
800-759-9305
Indirizzo
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Confronta SNOA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.7299 | 5.26M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
150.79 | 70.46B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.73 | 47.78B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.61 | 45.15B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.14 | 19.16B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
299.73 | 13.56B | 2.99B | 1.21B | 1.13B | 25.06 |
Sonoma Pharmaceuticals Inc Borsa (SNOA) Ultime notizie
Why Alector Inc. stock attracts strong analyst attentionLong Term Safe Yield Focus - Newser
Why Sonoma Pharmaceuticals Inc. stock attracts strong analyst attentionRapid Gain Targets - Newser
How NOEMW stock performs during market volatilityFree Risk Assessment Services - Newser
How Sonoma Pharmaceuticals Inc. stock performs during market volatilityDaily Breakout Picks - Newser
How NI Holdings Inc. stock performs during market volatilityMomentum Swing Watchlist - Newser
How Bar Harbor Bankshares stock performs during market volatilityHigh Accuracy Alerts - Newser
What makes Sonoma Pharmaceuticals Inc. stock price move sharplyFree Stock Portfolio Optimization - Newser
VOXEL(voxies) News and UpdatesCarefully Curated High Return Stocks - Newser
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance
U.S. Animal Wound Care Market Size | Industry Report, 2030 - Grand View Research
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Pass Above 200 Day Moving Average – Time to Sell? - Defense World
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Is Sonoma Pharmaceuticals, Inc. technically bullish or bearish? - MarketsMojo
Global Dental Market Set to Reach USD 19.13 Bn by 2032, Driven by 7.5% CAGR | Coherent Market Insights - newstrail.com
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | SNOA Stock News - GuruFocus
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results - ACCESS Newswire
Sonoma Pharmaceuticals, Inc. SEC 10-K Report - TradingView
SONOMA PHARMACEUTICALS Earnings Preview: Recent $SNOA Insider Trading, Hedge Fund Activity, and More - Nasdaq
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
Dental Market Set to Witness Robust Growth Fueled by Aesthetic - openPR.com
Keloid Treatment Market Exclusive Trends Analysis with Forecast to 2034 - openPR.com
Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews
Hospital Surgical Disinfectants Market Is Booming So Rapidly - openPR.com
Williams-Sonoma, Inc. (NYSE:WSM) Given Consensus Rating of “Hold” by Analysts - Defense World
Scar Treatment Market Is Booming So Rapidly | Merz, Lumenis, Sientra - newstrail.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Crosses Above 200-Day Moving Average – Time to Sell? - Defense World
Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - Business Wire
Netflix To $1,220? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Sonoma Biotherapeutics Appoints Rajesh Krishnan, Ph.D., as Chief Technical Officer - citybiz
Keloid Treatment Market Development Accelerated by Consumer - openPR.com
Pre-market Movers: KTTA, SXTC, GLMD, TCMD... - RTTNews
Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Checking in on Sonoma Pharmaceuticals Inc (SNOA) after recent insiders movement - knoxdaily.com
A Piece Of The Puzzle Missing From Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) 35% Share Price Climb - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Stocks of Sonoma Pharmaceuticals Inc (SNOA) are poised to climb above their peers - Sete News
Sonoma Pharmaceuticals (SNOA) Expands Acne Product Line to UK Re - GuruFocus
Sonoma Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
Financial Analysis: Integra Resources Corp (ITRG)’s Ratios Unveil Key Insights - DWinneX
Metric Deep Dive: Understanding Sonoma Pharmaceuticals Inc (SNOA) Through its Ratios - DWinneX
Analyzing SNOA’s price-to-book ratio for the last quarter - uspostnews.com
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views - Benzinga
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Benzinga
Sonoma Pharmaceuticals Inc (SNOA) Stock: A Year of Declines and Increases - investchronicle.com
Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX
Financial Snapshot: Analyzing Phio Pharmaceuticals Corp (PHIO)’s Key Ratio Metrics - DWinneX
UK Retail Deal Sparks Early Buying Frenzy in Pharma Stock - The Globe and Mail
Daily Progress: 60 Degrees Pharmaceuticals Inc (SXTP) Drop -15.51, Closing at 2.67 - DWinneX
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Sonoma Pharmaceuticals Poised to Sell Acne Products in UK; Shares Soar Premarket - marketscreener.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above 200-Day Moving Average – Here’s Why - Defense World
Sonoma Pharmaceuticals Inc Azioni (SNOA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.08%
2.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):